Madrigal Pharmaceuticals (MDGL) Non-Current Deferred Tax Liability (2016 - 2020)

Madrigal Pharmaceuticals (MDGL) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $14000.0 in Q4 2020.

• Non-Current Deferred Tax Liability for Q4 2020 came in at $14000.0, down 77.42% year-over-year; the trailing twelve-month figure through Dec 2020 was $14000.0 (down 77.42% YoY), and the FY2020 annual result was $14000.0, down 77.42% from the prior year.
• Non-Current Deferred Tax Liability fell to $14000.0 in Q4 2020 per MDGL's latest filing, from $62000.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $283000.0 in Q4 2016 and troughed at $14000.0 in Q4 2020.
• A 3-year average of $119666.7 and a median of $62000.0 in 2019 frame the typical range for Non-Current Deferred Tax Liability.
• On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 77.42% in 2020 and fell as far as 77.42% in 2020.
• A 3-year view of Non-Current Deferred Tax Liability shows it stood at $283000.0 in 2016, then plunged by 78.09% to $62000.0 in 2019, then tumbled by 77.42% to $14000.0 in 2020.
• Business Quant data shows MDGL's Non-Current Deferred Tax Liability at $14000.0 in Q4 2020, $62000.0 in Q4 2019, and $283000.0 in Q4 2016.